Transdermal composition containing donepezil as active ingredient
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jan 12, 2021
Grant Date -
Oct 12, 2017
app pub date -
Jun 16, 2017
filing date -
Dec 18, 2014
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention relates to a transdermal composition for dementia treatment containing donepezil as an active ingredient. The transdermal composition according to the present invention contains highly concentrated donepezil in a hydrophobic matrix, can continuously release the drug for a long time by having excellent long-term adhesion to the skin, and further exhibits consistently effective therapeutic effects over a long period of time by having a significantly improved skin penetration rate in comparison with conventional donepezil patches.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully